Actinium Pharmaceuticals Inc. (ATNM) |
|
0.4641 -0.039 (-7.73%)
|
03-25 13:54 |
|
Open: |
0.49 |
Pre. Close: |
0.503 |
|
High:
|
0.5 |
Low:
|
0.44 |
|
Volume:
|
1,093,482 |
Market Cap:
|
54M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.533 - 0.539 |
0.539 - 0.542 |
|
Low:
|
0.48 - 0.486 |
0.486 - 0.49 |
|
Close:
|
0.493 - 0.503 |
0.503 - 0.509 |
|
|
|
Technical analysis |
as of: 2019-03-25 1:28:11 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 0.71  One year: 0.83 |
| Support: |
Support1: 0.44 Support2: 0.37 |
| Resistance: |
Resistance1: 0.61 Resistance2: 0.71 |
| Pivot: |
0.56 |
| Moving Average: |
MA(5): 0.52 MA(20): 0.57
MA(100): 0.51 MA(250): 0.55  |
| MACD: |
MACD(12,26): -0.01 Signal(9): |
| Stochastic oscillator: |
%K(14,3): 7.53 %D(3): 7.88 |
| RSI: |
RSI(14): 31.35 |
| 52-week: |
High: 0.87 Low: 0.33 Change(%): 23.5 |
| Average Vol(K): |
3-Month: 77864 10-Days: 66806 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.ATNM has closed below the lower band by 11.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 22 Oct 2018 14:07:36 Z
Has Actinium Pharmaceuticals (ATNM) Outpaced Other Medical Stocks This Year?
Tue, 09 Jan 2018 16:14:37 Z
PTC Therapeutics (PTCT) Jumps: Stock Rises 12.9%
Mon, 08 Jan 2018 18:02:41 Z
Zacks.com featured highlights include: Western Digital, Hecla Mining, Sphere 3D, Actinium Pharmaceuticals and Southern National Bancorp
Fri, 05 Jan 2018 14:11:51 Z
Beat the Market with Rising P/E Technique
Thu, 28 Dec 2017 17:15:29 Z
Actinium Posts Positive DMC View on Lomab-B Phase III Trial
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
119.14 |
| Shares Float (M) |
118.71 |
|
% Held by Insiders
|
0.50 |
|
% Held by Institutions
|
12.40 |
|
Shares Short (K)
|
2798 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.100 |
|
EPS Est. Current Year
|
-0.400 |
|
EPS Est. Next Year
|
-0.250 |
|
EPS Est. Next Quarter
|
-0.080 |
|
Forward EPS
|
-0.090 |
|
Book Value (p.s.)
|
6.960 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-142.4 |
|
Return on Equity (ttm)
|
-210.4 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-19.45 |
|
Levered Free Cash Flow (M)
|
-11.24 |
Stock Valuations |
|
P/E
|
-4.63 |
|
P/E Growth Ratio
|
-0.08 |
|
P/BV
|
0.07 |
|
P/S
|
|
|
P/CF
|
-2.84 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
